Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients

Susanne Mohr1, Xia Xi, Jie Tang

  • 1Department of Medicine, Case Western Reserve University, Center for Diabetes Research, Cleveland, Ohio 44106, USA. sxm38@po.cwru.edu

Diabetes
|March 28, 2002
PubMed

Insights

Early activation of caspases, key enzymes in apoptosis, occurs in diabetic retinopathy. This finding suggests caspases are potential therapeutic targets for managing this vision-threatening complication.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetic retinopathy involves apoptosis of retinal capillary cells.
  • Caspases are crucial enzymes in apoptosis but their role in diabetic retinopathy is unstudied.

Purpose of the Study:

  • To measure caspase activities in mouse retinas during diabetes progression.
  • To investigate the role of caspases in diabetic retinopathy development.

Main Methods:

  • Assessed activities of multiple caspases (caspase-1, -2, -3, -4, -6, -8, -9) in mouse retinas at various diabetes durations.
  • Analyzed caspase activities in human type 2 diabetic retinas and experimental galactosemia models.

Main Results:

  • Several caspases were activated as early as 2 months in diabetic mouse retinas.
  • Executioner caspases (caspase-6, -3) activities increased with longer diabetes duration.
  • Elevated caspase activities (caspase-1, -3, -4, -6) were observed in human diabetic retinas.

Conclusions:

  • Caspase activation is an early event in diabetic retinopathy.
  • Caspase cascades play a significant role in the development of diabetic retinopathy.
  • Caspases represent promising therapeutic targets for diabetic retinopathy.